22 completed. 22 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 22 |
| Phase 2 | 4 | Completed 4 |
Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Completed | Mazandaran University of Medical Sciences | 90 | 2021-08-08 | 2023-10-19 |
| Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II Ticagrelor and Aspirin, Clopidogrel and Aspirin - Stroke, Transient Ischemic Attack | Phase 3 | Completed | Beijing Tiantan Hospital | 6412 | 2019-09-23 | 2021-12-02 |
| THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death Ticagrelor, Placebo - Acute Ischaemic Stroke, Transient Ischaemic Attack | Phase 3 | Completed | AstraZeneca | 11016 | 2018-01-22 | 2020-12-22 |
| Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke Colchicine - Ischemic Attack, Transient, Stroke | Phase 3 | Completed | University College Dublin | 3154 | 2016-12-12 | 2025-03-13 |
| Platelet Reactivity in Acute Non-disabling Cerebrovascular Events Ticagrelor and Acetylsalicylic acid, Clopidogrel and Acetylsalicylic acid - Stroke, Ischemic Attack, Transient | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 675 | 2015-08-01 | 2020-07-24 |
| Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation Apixaban, Warfarin - Transient Ischemic Attack, Stroke | Phase 3 | Completed | University of South Florida | 91 | 2015-04-01 | 2021-11-30 |
| Field Randomization of Nerinetide (NA-1) Therapy in Early Responders Nerinetide (NA-1), Placebo - Acute Cerebral Ischemia | Phase 3 | Completed | NoNO Inc. | 532 | 2015-03-26 | 2023-05-12 |
| [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] ticagrelor, Acetylsalicylic acid (ASA) - Acute Ischaemic Stroke, Transient Ischaemic Attack | Phase 3 | Completed | AstraZeneca | 13307 | 2014-01-07 | 2017-06-12 |
| Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion Rivaroxaban (Xarelto, BAY59-7939), Vitamin K antagonist (VKA) - Atrial Fibrillation | Phase 3 | Completed | Bayer | 1504 | 2012-10-01 | 2015-04-30 |
| Gadobutrol Enhanced MRA of the Supra-aortic Vessels Gadobutrol (Gadovist, BAY86-4875) - Carotid Stenosis | Phase 3 | Completed | Bayer | 479 | 2011-05-12 | 2019-01-04 |
| Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events Clopidogrel, Placebo of clopidogrel and Asprin - Stroke, Transient Ischemic Attack | Phase 3 | Completed | Beijing Tiantan Hospital | 5100 | 2009-12-01 | 2020-07-15 |
| Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 225 | 2008-12-23 | 2017-06-14 |
| Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034) Telcagepant, Acetaminophen/Paracetamol, Placebo to Telcagepant - Migraine Disorders, Heart Disease | Phase 3 | Completed | Merck Sharp & Dohme LLC | 165 | 2008-03-17 | 2018-10-19 |
| Cardiac Rehabilitation for TIA Patients Comprehensive Cardiac Rehabilitation (CR) - TIA (Transient Ischemic Attack) | Phase 3 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 132 | 2007-09-01 | 2019-08-13 |
| Home Blood Pressure Monitoring Trial Intervention - a validated home BP monitor and support from the specialist nurse, Control - usual care (BP monitoring by their practice) - Stroke, Ischemic Attack, Transient | Phase 3 | Completed | St George's, University of London | 360 | 2007-03-01 | 2015-06-09 |
| WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation WATCHMAN Left Atrial Appendage Closure Technology, Warfarin - Atrial Fibrillation, Stroke | Phase 2 / Phase 3 | Completed | Boston Scientific Corporation | 800 | 2005-02-01 | 2015-05-15 |
| Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Cerebral Stroke, Ischemic Attack, Transient | Phase 3 | Completed | AstraZeneca | 1700 | 2003-06-01 | 2010-11-15 |
| Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Cerebral Stroke, Stroke, Acute | Phase 3 | Completed | AstraZeneca | 3200 | 2003-05-01 | 2010-11-15 |
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) Aspirin, Clopidogrel, Simvastatin - Transient Ischemic Attack, Stroke | Phase 2 / Phase 3 | Completed | University of Calgary | 500 | 2003-05-01 | 2008-04-08 |
| Aortic Arch Related Cerebral Hazard Trial (ARCH) Warfarin, Clopidogrel-aspirin - Brain Infarction, Transient Ischemic Attack | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 350 | 2002-02-01 | 2012-07-10 |
Showing 20 of 22. Sign in to see all of them.
Stroke (17) · Atrial Fibrillation (3) · Carotid Stenosis (2) · Hypertension (2) · Ischemia (2) · Ischemic Stroke (2) · Recurrence (2) · Atherosclerosis (1) · Brain Infarction (1) · Brain Ischemia (1) · Cataplexy (1) · Embolism (1) · Heart Diseases (1) · Hemorrhage (1)
Brain Diseases (22) · Cardiovascular Diseases (22) · Central Nervous System Diseases (22) · Cerebrovascular Disorders (22) · Nervous System Diseases (22) · Brain Ischemia (21) · Vascular Diseases (21) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Arrhythmias, Cardiac (3) · Embolism and Thrombosis (3) · Heart Diseases (3) · Stroke (3) · Arterial Occlusive Diseases (2) · Carotid Artery Diseases (2)
Aspirin (5) · Clopidogrel (5) · Ticagrelor (5) · Warfarin (3) · disufenton sodium (2) · Acetaminophen (1) · Cardiac Rehabilitation (1) · Colchicine (1) · Rivaroxaban (1) · Simvastatin (1) · Stents (1) · acarboxyprothrombin (1) · apixaban (1) · gadobutrol (1) · telcagepant (1)
AstraZeneca (4) · Beijing Tiantan Hospital (3) · Assistance Publique - Hôpitaux de Paris (2) · Bayer (2) · Boston Scientific Corporation (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Mazandaran University of Medical Sciences (1) · Merck Sharp & Dohme LLC (1) · NoNO Inc. (1) · St George's, University of London (1) · University College Dublin (1) · University of Calgary (1) · University of South Florida (1) · VA Office of Research and Development (1)
United States (9) · Canada (8) · China (8) · Germany (8) · France (7) · Czechia (6) · Argentina (5) · Australia (5) · Belgium (5) · Poland (5) · Spain (5) · United Kingdom (5) · Brazil (4) · Italy (4) · South Korea (4)
Alastair M Buchan (1) · Athena Sharifi-Razavi (1) · Cheryl Fontana, BSN (1) · David Holmes, MD (1) · Dawn M. Bravata, MD (1) · James Kennedy (1) · Jim Christenson, M.D. (1) · L. Nelson Hopkins, MD (1) · Michael Fradley, M.D. (1) · Neville G. Suskin, MBChB, MSc (1) · Pierre Amarenco, Pr, MD, PhD (1) · Prof Peter Kelly (1)
PMID 29915123, PMID 16467546, PMID 17050890, PMID 17687131, PMID 17931979, PMID 18353175, PMID 18774745, PMID 19683639, PMID 20542776, PMID 21242484, PMID 21885958, PMID 22221076, PMID 22334806, PMID 22968110, PMID 23128283, PMID 23237679, PMID 23325525, PMID 23500276, PMID 23803136, PMID 24458967, PMID 24699050, PMID 25082808, PMID 25399274, PMID 25957224, PMID 26012640, PMID 26330567, PMID 26627989, PMID 27001965, PMID 27160892, PMID 27160944, PMID 27328699, PMID 27613582, PMID 27738237, PMID 27899747, PMID 28238711, PMID 28289237, PMID 28381198, PMID 28455318, PMID 28655834, PMID 28720658, PMID 28959461, PMID 29051218, PMID 29507777, PMID 29773949, PMID 30089614, PMID 30355101, PMID 30355199, PMID 30355202, PMID 30621613, PMID 30742211
2015 (1), 2016 (1)